Text Size:AAA

人 COMP HEK293 过表达细胞裂解液 (阳性对照)

产品数据评论实验方法
表达宿主: Human Cells  
  • Slide 1
10173-H08H-50
10173-H08H-100
50 µg 
100 µg 
Add to Cart
反应性: Human  
应用 : ELISA  
    10173-MM02-50
    10173-MM02-100
    10173-MM02-1
    50 µg 
    100 µg 
    1 mg 
    Add to Cart
    反应性: Human  
    应用 : ELISA  
      10173-RP03-50
      10173-RP03-200
      10173-RP03-100
      50 µg 
      200 µg 
      100 µg 
      Add to Cart
      反应性: Human  
      应用 : ELISA  
        10173-RP01-400
        10173-RP01-200
        10173-RP01-100
        400 µg 
        200 µg 
        100 µg 
        Add to Cart

        COMP 细胞裂解液Related Products

        Related Products

        Featured Reagent Products

        COMP lysate_category 研究背景

        Cartilage Oligomeric Matrix Protein (COMP), also referred to as Thrombospondin-5, is a non-collagenous extracellular matrix (ECM) protein and belongs to the subgroup B of the thrombospondin protein family. This protein is expressed primarily in cartilage, ligament, and tendon, and binds to other ECM proteins such as collagen I, II and IX with high affinities depending on the divalent cations Zn2+ or Ni2+. COMP is a secreted glycoprotein that is important for growth plate organization and function. It is suggested to play a role in cell growth and development, and recent studies have revealed the possible mechanism that it protects cells against death by elevating members of the IAP (inhibitor of apoptosis protein) family of survival proteins. Mutations in COMP cause two skeletal dysplasias, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (EDM1), and up-regulated expression of COMP are observed in rheumatoid arthritis and certain carcinomas.

         COMP lysate_category 参考资料
      • Posey KL, et al. (2004) Role of TSP-5/COMP in pseudoachondroplasia. Int J Biochem Cell Biol. 36(6): 1005-12.
      • Chen FH, et al. (2005) Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem. 282(34): 24591-8.
      • Posey KL, et al. (2008) The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets. 9(10): 869-77.
      • Tan K, et al. (2009) The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding. FASEB J. 23(8): 2490-501.
      • 请注意:所有产品都是“仅用于科研,而不能用于诊断或治疗用途”